标题
100 years of Bacillus Calmette–Guérin immunotherapy: from cattle to COVID-19
作者
关键词
-
出版物
Nature Reviews Urology
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2021-06-15
DOI
10.1038/s41585-021-00481-1
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Reconcile the debate over protective effects of BCG vaccine against COVID-19
- (2021) Wei Fu et al. Scientific Reports
- Preparedness and vulnerability of African countries against importations of COVID-19: a modelling study
- (2020) Marius Gilbert et al. LANCET
- An interactive web-based dashboard to track COVID-19 in real time
- (2020) Ensheng Dong et al. LANCET INFECTIOUS DISEASES
- Prevention of tuberculosis in macaques after intravenous BCG immunization
- (2020) Patricia A. Darrah et al. NATURE
- Is BCG vaccination affecting the spread and severity of COVID‐19?
- (2020) Cevdet Ozdemir et al. ALLERGY
- Risks from Deferring Treatment for Genitourinary Cancers: A Collaborative Review to Aid Triage and Management During the COVID-19 Pandemic
- (2020) Christopher J.D. Wallis et al. EUROPEAN UROLOGY
- Adjustments in the Use of Intravesical Instillations of Bacillus Calmette-Guérin for High-risk Non-muscle-invasive Bladder Cancer During the COVID-19 Pandemic
- (2020) Louis Lenfant et al. EUROPEAN UROLOGY
- SARS-CoV-2 Rates in BCG-Vaccinated and Unvaccinated Young Adults
- (2020) Uri Hamiel et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Considering BCG vaccination to reduce the impact of COVID-19
- (2020) Nigel Curtis et al. LANCET
- Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China
- (2020) Chaomin Wu et al. JAMA Internal Medicine
- BCG Vaccination in Humans Elicits Trained Immunity via the Hematopoietic Progenitor Compartment
- (2020) Branko Cirovic et al. Cell Host & Microbe
- BCG vaccination early in life does not improve COVID‐19 outcome of elderly populations, based on nationally reported data
- (2020) Trudy M. Wassenaar et al. LETTERS IN APPLIED MICROBIOLOGY
- Trained immunity as a molecular mechanism for BCG immunotherapy in bladder cancer
- (2020) Jelmer H. van Puffelen et al. Nature Reviews Urology
- BCG vaccine protection from severe coronavirus disease 2019 (COVID-19)
- (2020) Luis E. Escobar et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mandated Bacillus Calmette-Guérin (BCG) vaccination predicts flattened curves for the spread of COVID-19
- (2020) Martha K. Berg et al. Science Advances
- Activate: Randomized Clinical Trial of BCG Vaccination against Infection in the Elderly
- (2020) Evangelos J. Giamarellos-Bourboulis et al. CELL
- Bacille Calmette-Guérin Vaccination in Infancy Does Not Protect Against Coronavirus Disease 2019 (COVID-19): Evidence From a Natural Experiment in Sweden
- (2020) Clément de Chaisemartin et al. CLINICAL INFECTIOUS DISEASES
- BCG as an adjunct or alternative vaccine to prevent COVID-19?
- (2020) Chien-Hsiang Weng et al. JOURNAL OF TRAVEL MEDICINE
- BCG epidemiology supports its protection against COVID-19? A word of caution
- (2020) Reka Szigeti et al. PLoS One
- Lack of evidence for BCG vaccine protection from severe COVID-19
- (2020) Cecilia S. Lindestam Arlehamn et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- BCG vaccination history associates with decreased SARS-CoV-2 seroprevalence across a diverse cohort of health care workers
- (2020) Magali Noval Rivas et al. JOURNAL OF CLINICAL INVESTIGATION
- BCG vaccination in health care providers and the protection against COVID-19
- (2020) Mihai G. Netea et al. JOURNAL OF CLINICAL INVESTIGATION
- Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
- (2020) Merryn Voysey et al. LANCET
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
- (2020) Lindsey R. Baden et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
- Recombinant BCG overexpressing STING agonist elicits trained immunity and improved antitumor efficacy in non-muscle invasive bladder cancer
- (2020) AK Singh et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Reserving coronavirus disease 2019 vaccines for global access: cross sectional analysis
- (2020) Anthony D So et al. BMJ-British Medical Journal
- Outcomes of controlled human malaria infection after BCG vaccination
- (2019) Jona Walk et al. Nature Communications
- BCG overexpressing an endogenous STING agonist provides enhanced protection against pulmonary tuberculosis
- (2019) Ruchi Jain Dey et al. JOURNAL OF INFECTIOUS DISEASES
- European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 Update
- (2019) Marko Babjuk et al. EUROPEAN UROLOGY
- Comparative Effectiveness of Intravesical BCG-Tice and BCG-Moreau in Patients With Non–muscle-invasive Bladder Cancer
- (2019) David D’Andrea et al. Clinical Genitourinary Cancer
- Early vaccination with BCG-Denmark or BCG-Japan versus BCG-Russia to healthy newborns in Guinea-Bissau: A randomized controlled trial
- (2019) Frederik Schaltz-Buchholzer et al. CLINICAL INFECTIOUS DISEASES
- BCG Educates Hematopoietic Stem Cells to Generate Protective Innate Immunity against Tuberculosis
- (2018) Eva Kaufmann et al. CELL
- BCG Vaccination Protects against Experimental Viral Infection in Humans through the Induction of Cytokines Associated with Trained Immunity
- (2018) Rob J.W. Arts et al. Cell Host & Microbe
- The cGAS–cGAMP–STING pathway connects DNA damage to inflammation, senescence, and cancer
- (2018) Tuo Li et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Mechanisms of BCG immunotherapy and its outlook for bladder cancer
- (2018) Caroline Pettenati et al. Nature Reviews Urology
- Prevention of M. tuberculosis Infection with H4:IC31 Vaccine or BCG Revaccination
- (2018) Elisa Nemes et al. NEW ENGLAND JOURNAL OF MEDICINE
- Determinants of BCG scarification among children in rural Guinea-Bissau: A prospective cohort study
- (2018) Katarina M. Funch et al. Human Vaccines & Immunotherapeutics
- Phase 2b Controlled Trial of M72/AS01E Vaccine to Prevent Tuberculosis
- (2018) Olivier Van Der Meeren et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy of bacillus Calmette-Guérin Strains for Treatment of Nonmuscle Invasive Bladder Cancer: A Systematic Review and Network Meta-Analysis
- (2017) Brock E. Boehm et al. JOURNAL OF UROLOGY
- Recombinant BCG Expressing ESX-1 of Mycobacterium marinum Combines Low Virulence with Cytosolic Immune Signaling and Improved TB Protection
- (2017) Matthias I. Gröschel et al. Cell Reports
- Safety and Immunogenicity of the Recombinant Mycobacterium bovis BCG Vaccine VPM1002 in HIV-Unexposed Newborn Infants in South Africa
- (2016) André G. Loxton et al. Clinical and Vaccine Immunology
- Cytokine Panel for Response to Intravesical Therapy (CyPRIT): Nomogram of Changes in Urinary Cytokine Levels Predicts Patient Response to Bacillus Calmette-Guérin
- (2016) Ashish M. Kamat et al. EUROPEAN UROLOGY
- EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and Disease-specific and Overall Survival in Non–Muscle-invasive Stage Ta–T1 Urothelial Bladder Cancer Patients Treated with 1–3 Years of Maintenance Bacillus Calmette-Guérin
- (2016) Samantha Cambier et al. EUROPEAN UROLOGY
- Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer: AUA/SUO Guideline
- (2016) Sam S. Chang et al. JOURNAL OF UROLOGY
- Bladder cancer
- (2016) Ashish M Kamat et al. LANCET
- Duration of BCG protection against tuberculosis and change in effectiveness with time since vaccination in Norway: a retrospective population-based cohort study
- (2016) Patrick Nguipdop-Djomo et al. LANCET INFECTIOUS DISEASES
- Trained immunity: A program of innate immune memory in health and disease
- (2016) M. G. Netea et al. SCIENCE
- The efficacy of BCG TICE and BCG Connaught in a cohort of 2,099 patients with T1G3 non–muscle-invasive bladder cancer
- (2016) J. Alfred Witjes et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Different effects of BCG strains – A natural experiment evaluating the impact of the Danish and the Russian BCG strains on morbidity and scar formation in Guinea-Bissau
- (2016) H. Frankel et al. VACCINE
- Immunometabolic Pathways in BCG-Induced Trained Immunity
- (2016) Rob J.W. Arts et al. Cell Reports
- Editorial Commentary: Different Strains of Bacillus Calmette–Guérin Vaccine Have Very Different Effects on Tuberculosis and on Unrelated Infections
- (2015) Frank Shann CLINICAL INFECTIOUS DISEASES
- Nonspecific (Heterologous) Protection of Neonatal BCG Vaccination Against Hospitalization Due to Respiratory Infection and Sepsis
- (2015) María José de Castro et al. CLINICAL INFECTIOUS DISEASES
- BCG Vaccination Enhances the Immunogenicity of Subsequent Influenza Vaccination in Healthy Volunteers: A Randomized, Placebo-Controlled Pilot Study
- (2015) Jenneke Leentjens et al. JOURNAL OF INFECTIOUS DISEASES
- BCG-induced trained immunity in NK cells: Role for non-specific protection to infection
- (2014) Johanneke Kleinnijenhuis et al. CLINICAL IMMUNOLOGY
- Bacillus Calmette-Guérin Strain Differences Have an Impact on Clinical Outcome in Bladder Cancer Immunotherapy
- (2014) Cyrill A. Rentsch et al. EUROPEAN UROLOGY
- Systematic review and meta-analysis of the current evidence on the duration of protection by bacillus Calmette–Guérin vaccination against tuberculosis
- (2014) I Abubakar et al. HEALTH TECHNOLOGY ASSESSMENT
- Heterologous Immunological Effects of Early BCG Vaccination in Low-Birth-Weight Infants in Guinea-Bissau: A Randomized-controlled Trial
- (2014) Kristoffer Jarlov Jensen et al. JOURNAL OF INFECTIOUS DISEASES
- The mechanism of action of BCG therapy for bladder cancer—a current perspective
- (2014) Gil Redelman-Sidi et al. Nature Reviews Urology
- mTOR- and HIF-1 -mediated aerobic glycolysis as metabolic basis for trained immunity
- (2014) S.-C. Cheng et al. SCIENCE
- Disseminated infection due toMycobacterium bovisafter intravesical BCG instillation
- (2014) Sara Marquez-Batalla World Journal of Clinical Cases
- Bacillus Calmette-Guérin immunotherapy for genitourinary cancer
- (2013) Nilay M. Gandhi et al. BJU INTERNATIONAL
- Protection by BCG Vaccine Against Tuberculosis: A Systematic Review of Randomized Controlled Trials
- (2013) Punam Mangtani et al. CLINICAL INFECTIOUS DISEASES
- Maintenance Bacillus Calmette-Guérin Treatment of Non–muscle-invasive Bladder Cancer: A Critical Evaluation of the Evidence
- (2013) Behfar Ehdaie et al. EUROPEAN UROLOGY
- Side Effects of Bacillus Calmette-Guérin (BCG) in the Treatment of Intermediate- and High-risk Ta, T1 Papillary Carcinoma of the Bladder: Results of the EORTC Genito-Urinary Cancers Group Randomised Phase 3 Study Comparing One-third Dose with Full Dose and 1 Year with 3 Years of Maintenance BCG
- (2013) Maurizio Brausi et al. EUROPEAN UROLOGY
- Immune Sensing of DNA
- (2013) Søren R. Paludan et al. IMMUNITY
- BCG immunotherapy for bladder cancer—the effects of substrain differences
- (2013) Christine Gan et al. Nature Reviews Urology
- Molecular Analysis of Non-Specific Protection against Murine Malaria Induced by BCG Vaccination
- (2013) Marcela Parra et al. PLoS One
- Pivotal Roles of cGAS-cGAMP Signaling in Antiviral Defense and Immune Adjuvant Effects
- (2013) X.-D. Li et al. SCIENCE
- A small jab – a big effect: nonspecific immunomodulation by vaccines
- (2013) Christine S. Benn et al. TRENDS IN IMMUNOLOGY
- The Effect of Fibrin Clot Inhibitors on the Immunomodulatory Efficacy of Bacillus Calmette-Guérin Therapy for Non–muscle-invasive Bladder Cancer
- (2013) Michael J. Lipsky et al. UROLOGY
- Final Results of an EORTC-GU Cancers Group Randomized Study of Maintenance Bacillus Calmette-Guérin in Intermediate- and High-risk Ta, T1 Papillary Carcinoma of the Urinary Bladder: One-third Dose Versus Full Dose and 1 Year Versus 3 Years of Maintenance
- (2012) Jorg Oddens et al. EUROPEAN UROLOGY
- Comparative Tuberculosis (TB) Prevention Effectiveness in Children of Bacillus Calmette-Guérin (BCG) Vaccines from Different Sources, Kazakhstan
- (2012) Michael Favorov et al. PLoS One
- Bacille Calmette-Guerin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes
- (2012) J. Kleinnijenhuis et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Non-specific and sex-differential effects of vaccinations on child survival in rural western India
- (2012) Siddhivinayak Hirve et al. VACCINE
- The influence of BCG vaccine strain on mycobacteria-specific and non-specific immune responses in a prospective cohort of infants in Uganda
- (2012) Elizabeth J. Anderson et al. VACCINE
- Trained Immunity: A Memory for Innate Host Defense
- (2011) Mihai G. Netea et al. Cell Host & Microbe
- Randomized Trial of BCG Vaccination at Birth to Low-Birth-Weight Children: Beneficial Nonspecific Effects in the Neonatal Period?
- (2011) Peter Aaby et al. JOURNAL OF INFECTIOUS DISEASES
- Small Randomized Trial Among Low–birth-weight Children Receiving Bacillus Calmette-Guéerin Vaccination at First Health Center Contact
- (2011) Sofie Biering-Sørensen et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Pediatric Tuberculosis: Global Overview and Challenges
- (2010) Soumya Swaminathan et al. CLINICAL INFECTIOUS DISEASES
- An Individual Patient Data Meta-Analysis of the Long-Term Outcome of Randomised Studies Comparing Intravesical Mitomycin C versus Bacillus Calmette-Guérin for Non–Muscle-Invasive Bladder Cancer
- (2009) Per-Uno Malmström et al. EUROPEAN UROLOGY
- STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity
- (2009) Hiroki Ishikawa et al. NATURE
- Mapping the global use of different BCG vaccine strains
- (2009) Nicole Ritz et al. TUBERCULOSIS
- STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling
- (2008) Hiroki Ishikawa et al. NATURE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now